EUVIMEDEUVIMED entdecken
Crossref

Correlation between bradykinin concentration and blood pressure during Rheocarna therapy: A single‐center case series

Takaya Handa iD, Masaki Fujii, Masumi Ando, Mayumi Masuda, Yuko Sokai, Yoshiki Tsuji, Yui Fukuda, Kaoru Ohue, Yoshiaki Higashi, Keita P Mori, Tomomi Endo, Tatsuo Tsukamoto

Therapeutic Apheresis and Dialysis · 2024-06 · 28 (3) · 453-459

DOI: 10.1111/1744-9987.14105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 03.01.2024. Verfasst von Takaya Handa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan. Hauptthemen laut MEDLINE: Bradykinin, Blood Pressure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A novel LDL (low‐density lipoprotein) apheresis therapeutic option, Rheocarna, has garnered attention as an alternative therapy for chronic limb‐threating ischemia (CLTI). Bradykinin‐mediated vasodilation is involved in the effects of LDL apheresis and a decrease in blood pressure (BP), but the changes in bradykinin concentration during Rheocarna therapy are unknown.

Methods

The study involved patients with CLTI treated with Rheocarna at our hospital, from April 2022 to August 2023.

Results

After Rheocarna therapy, skin ulcers improved in 80% of the patients. Circuit coagulation was observed in two patients with high fibrinogen levels. A decrease in BP was observed at approximately the same time when the bradykinin concentration peaked. The peak bradykinin concentration in a patient undergoing hemodialysis at the same time was considerably lower than that in the other patients.

Conclusion

This is the first report on the changes in bradykinin concentration under Rheocarna therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BradykininBlood PressureHumansMaleFemaleAgedMiddle AgedBlood Component RemovalIschemiaLipoproteins, LDL

Stichwörter der Autor:innen

LDL apheresisRheocarnabradykininchronic limb‐threating ischemiahemodialysis patients

Substanzen

BradykininLipoproteins, LDL

Autor:innen und Institutionen

  • Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan.
  • Department of Clinical Engineering, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan.
  • Department of the Blood Purification Center of Kitano Hospital, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan.

ORCID-Profile: Takaya Handa

Zitieren

APA

Handa, T., Fujii, M., Ando, M., Masuda, M., Sokai, Y., Tsuji, Y., Fukuda, Y., Ohue, K., Higashi, Y., Mori, K. P., Endo, T., & Tsukamoto, T. (2024). Correlation between bradykinin concentration and blood pressure during Rheocarna therapy: A single‐center case series. Therapeutic Apheresis and Dialysis, 28(3), 453-459. https://doi.org/10.1111/1744-9987.14105

Vancouver

Handa T, Fujii M, Ando M, Masuda M, Sokai Y, Tsuji Y, et al. Correlation between bradykinin concentration and blood pressure during Rheocarna therapy: A single‐center case series. Therapeutic Apheresis and Dialysis. 2024;28(3):453-459. doi:10.1111/1744-9987.14105

BibTeX
@article{Handa2024,
  author = {Handa, Takaya and Fujii, Masaki and Ando, Masumi and Masuda, Mayumi and Sokai, Yuko and Tsuji, Yoshiki and Fukuda, Yui and Ohue, Kaoru and Higashi, Yoshiaki and Mori, Keita P and Endo, Tomomi and Tsukamoto, Tatsuo},
  title = {Correlation between bradykinin concentration and blood pressure during Rheocarna therapy: A single‐center case series},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  volume = {28},
  number = {3},
  pages = {453--459},
  doi = {10.1111/1744-9987.14105}
}
Kostenlos starten →